CJC-1295 No DAC 5mg/10mg Research Peptide

For Research Purposes Only. Not approved for human consumption.

CJC-1295 No DAC Research Peptide 10mg

CJC-1295 without DAC (Modified GRF 1-29) is a synthetic analog of the first 29 amino acids of endogenous GHRH. With a half-life of ~30 minutes it produces pulsatile GH release mimicking natural GH secretion rhythms — making it the preferred GHRH analog for physiologically accurate GH pulse research. Frequently combined with Ipamorelin for synergistic dual-pathway GH secretagogue studies.

Research Applications

• Pulsatile GH secretion pattern research
• Hypothalamic-pituitary axis studies
• IGF-1 regulation investigations
• Combination GHRH + GHRP protocols
• Body composition and metabolic research

Quality Specifications

• Purity: ≥98% (HPLC verified)
• Compound: CJC-1295 (No DAC)
• Molecular Weight: 3367.9 Da
• Form: Lyophilized powder
• Storage: -20°C, protect from light
• COA: Batch-specific, ISO-accredited laboratory

Frequently Asked Questions

Q: DAC vs. No DAC — which do I choose?
A: No DAC (30 min half-life) mimics natural pulsatile GH physiology. DAC (6-8 day half-life) produces sustained, continuous GH stimulation. Choose based on your research design.

Q: Why combine with Ipamorelin?
A: CJC-1295 No DAC targets GHRH receptors; Ipamorelin targets ghrelin receptors. Two independent pathways produce synergistic GH release.

Q: What downstream effects does GHRH activation produce?
A: Pituitary GH release → hepatic IGF-1 production → effects on protein synthesis, fat metabolism, and cellular regeneration across multiple tissues.

Related Research: Ipamorelin | CJC-1295 DAC | Sermorelin | Hexarelin Research Peptide

For laboratory research use only. Not for human consumption. Not evaluated by the FDA.